SEC Form 4 · accession 0000899243-18-026708
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith Orford
Officer — SR. VP, CLINICAL DEVELOPMENT
Period of report
Oct 11, 2018
Accepted (ET)
Oct 15, 2018 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Oct 11, 2018 | S | 1,252 | $6.00 | D | 10,627 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on April 25, 2018.
- F2Includes 5,000 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 8, 2017 and June 8, 2018.